Cancer rates were about 68% higher among men who have never married compared with those who have, and roughly 83% higher for never-married women, according to new research. Married people tend to have greater economic stability and better support systems, and are more likely to stick with treatment, said professor Paulo Pinheiro, a co-author of the findings.

The Health newsletter takes you inside what’s new in health, medicine and personal well-being. If you’re not subscribed, sign up here.

Digital interactions are replacing face-to-face interactions, and the rise of AirPods means we’re all tuned into our own little worlds, writes Julie Jargon. In 2005, we spoke about 16,632 words every day. By 2019, that number had fallen to 11,900, according to researchers at the University of Missouri-Kansas City and the University of Arizona.

Experimental drugs are showing promise after years of little innovation. Earlier this week, New Haven, Conn.-based Veradermics reported promising late-stage trial results for a new hair-loss pill that’s being developed for men and women. It’s the latest in a string of hopeful results from companies developing new hair-loss treatments.

Cigna Group will exit the Affordable Care Act market next year, becoming the second major health insurer to leave the rapidly shrinking ACA market, after CVS Health’s Aetna stopped offering plans at the start of this year.

Eli Lilly shares jumped 10% as Mounjaro and Zepbound fueled massive growth. Booming sales of weight-loss shots fueled strong revenue and profit growth for the company in the latest quarter, as robust consumer demand helped offset falling prices for the drugs.

The Canadian government authorized a generic version of Ozempic developed by Dr. Reddy’s Laboratories, making it the first G-7 country to approve a generic version of the massively popular GLP-1 diabetes treatment.

How much a federal judge sentenced OxyContin maker Purdue Pharma to pay the government, ending the government’s yearslong criminal case and allowing the pharmaceutical company accused of fueling the opioid epidemic to wrap up a settlement deal to resolve many lawsuits.

• Could at-home brain stimulation reduce psychiatry’s reliance on SSRIs? (The New York Times)

• A new obesity tool aims to predict the risks of 18 serious complications. (STAT News)

• These tests claim to tell your “biological age,” but the science isn’t there yet. (The Washington Post)

The Health newsletter is your weekly guide to all the news that affects your health and well-being. This edition was curated and edited by Conor Grant—send him feedback or questions at conor.grant@wsj.com (if you’re reading this in your inbox, you can just hit reply). Got a tip for us? Here’s how to submit.